Carbon monoxide ‐releasing molecule‐3 (CORM‐3) offers protection in an in vitro model of compartment syndrome

ConclusionCORM ‐3 offers potent anti‐oxidant and anti‐inflammatory effects, and may have a potential application to patients at risk of developing CS.

Source: Microcirculation - July 18, 2019 Category: Research Authors: Aurelia Bihari, Kyukwang (Akira) Chung, Gediminas Cepinskas, David Sanders, Emil Schemitsch, Abdel ‐Rahman Lawendy Tags: ORIGINAL ARTICLE Source Type: research